Association of an Increased Abnormal Mitochondria Ratio in Cardiomyocytes with a Prolonged Oxygen Uptake Time Constant during Cardiopulmonary Exercise Testing of Patients with Non-ischemic Cardiomyopathy

Objective The cardiac function, blood distribution, and oxygen extraction in the muscles as well as the pulmonary function determine the oxygen uptake (VO2) kinetics at the onset of exercise. This factor is called the VO2 time constant, and its prolongation is associated with an unfavorable prognosis for heart failure (HF). The mitochondrial function of skeletal muscle is known to reflect exercise tolerance. Morphological changes and dysfunction in cardiac mitochondria are closely related to HF severity and its prognosis. Although mitochondria play an important role in generating energy in cardiomyocytes, the relationship between cardiac mitochondria and the VO2 time constant has not been elucidated. Methods We calculated the ratio of abnormal cardiac mitochondria in human myocardial biopsy samples using an electron microscope and measured the VO2 time constant during cardiopulmonary exercise testing. The VO2 time constant was normalized by the fat-free mass index (FFMI). Patients Fifteen patients with non-ischemic cardiomyopathy (NICM) were included. Patients were divided into two groups according to their median VO2 time constant/FFMI value. Results Patients with a low VO2 time constant/FFMI value had a lower abnormal mitochondria ratio than those with a high VO2 time constant/FFMI value. A multiple linear regression analysis revealed that the ratio of abnormal cardiac mitochondria was independently associated with a high VO2 time constant/FFMI. Conclusion An increased abnormal cardiac mitochondria ratio might be associated with a high VO2 time constant/FFMI value in patients with NICM.

[1]  B. Levine,et al.  Impaired oxygen uptake kinetics in heart failure with preserved ejection fraction , 2019, Heart.

[2]  D. Kelly,et al.  Mitochondrial Dysfunction in Heart Failure With Preserved Ejection Fraction , 2019, Circulation.

[3]  K. Nair,et al.  Mitochondrial Morphology, Dynamics, and Function in Human Pressure Overload or Ischemic Heart Disease With Preserved or Reduced Ejection Fraction , 2019, Circulation. Heart failure.

[4]  Dongxian Zhang,et al.  Mitochondrial Dynamics in Rat Heart Induced by 5-Fluorouracil , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[5]  A. Papavassiliou,et al.  Mitochondria and cardiovascular diseases-from pathophysiology to treatment. , 2018, Annals of translational medicine.

[6]  M. Mizuno,et al.  Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts , 2018, Physiological reports.

[7]  Abeer M. Rababa’h,et al.  Oxidative Stress and Cardiac Remodeling: An Updated Edge , 2018, Current cardiology reviews.

[8]  D. Bernstein,et al.  Physiological Mitochondrial Fragmentation Is a Normal Cardiac Adaptation to Increased Energy Demand , 2017, Circulation research.

[9]  I. Kubota,et al.  Sarcopenia evaluated by fat-free mass index is an important prognostic factor in patients with chronic heart failure. , 2015, European journal of internal medicine.

[10]  W. Kraus,et al.  Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction. , 2014, American journal of physiology. Heart and circulatory physiology.

[11]  V. Florea,et al.  Mechanisms for Cachexia in Heart Failure , 2013, Current Heart Failure Reports.

[12]  G. Lewis,et al.  Prolonged Mean Vo2 Response Time in Systolic Heart Failure: An Indicator of Impaired Right Ventricular-Pulmonary Vascular Function , 2013, Circulation. Heart failure.

[13]  D. Poole,et al.  Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance. , 2012, American journal of physiology. Heart and circulatory physiology.

[14]  H. Tsutsui,et al.  Oxidative stress and heart failure. , 2011, American journal of physiology. Heart and circulatory physiology.

[15]  Ross Arena,et al.  Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. , 2010, Circulation.

[16]  F. Esposito,et al.  Limited maximal exercise capacity in patients with chronic heart failure: partitioning the contributors. , 2010, Journal of the American College of Cardiology.

[17]  G. Forbes,et al.  Lean body mass-body fat interrelationships in humans. , 2009, Nutrition reviews.

[18]  Stefan Neubauer,et al.  The failing heart--an engine out of fuel. , 2007, The New England journal of medicine.

[19]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[20]  D. Muoio,et al.  Subsarcolemmal and intermyofibrillar mitochondria play distinct roles in regulating skeletal muscle fatty acid metabolism. , 2005, American journal of physiology. Cell physiology.

[21]  B. Korzeniewski,et al.  Training-induced adaptation of oxidative phosphorylation in skeletal muscles. , 2003, The Biochemical journal.

[22]  F. Marumo,et al.  Prognostic significance of cardiopulmonary exercise testing for 10-year survival in patients with mild to moderate heart failure. , 2000, Japanese circulation journal.

[23]  F. Follath,et al.  Oxygen uptake kinetics during low level exercise in patients with heart failure: relation to neurohormones, peak oxygen consumption, and clinical findings , 1999, Heart.

[24]  W. Willis,et al.  Differential responses to endurance training in subsarcolemmal and intermyofibrillar mitochondria. , 1998, Journal of applied physiology.

[25]  L. Tavazzi,et al.  Peak exercise oxygen consumption in chronic heart failure: toward efficient use in the individual patient. , 1998, Journal of the American College of Cardiology.

[26]  L. Shaw,et al.  Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. , 1996, Journal of the American College of Cardiology.

[27]  A. Nogami,et al.  Oxygen uptake kinetics are determined by cardiac function at onset of exercise rather than peak exercise in patients with prior myocardial infarction. , 1994, Circulation.

[28]  D. Mancini,et al.  Exertional Fatigue Due to Skeletal Muscle Dysfunction in Patients With Heart Failure , 1993, Circulation.

[29]  J R Wilson,et al.  Value of Peak Exercise Oxygen Consumption for Optimal Timing of Cardiac Transplantation in Ambulatory Patients With Heart Failure , 1991, Circulation.

[30]  S A Ward,et al.  Physiological determinants of pulmonary gas exchange kinetics during exercise. , 1990, Medicine and science in sports and exercise.

[31]  M. Higginbotham,et al.  Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. , 1989, Circulation.

[32]  S Nioka,et al.  Control of oxidative metabolism and oxygen delivery in human skeletal muscle: a steady-state analysis of the work/energy cost transfer function. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Mahler First-order kinetics of muscle oxygen consumption, and an equivalent proportionality between QO2 and phosphorylcreatine level. Implications for the control of respiration , 1985, The Journal of general physiology.

[34]  Akira Koike,et al.  Heart rate and blood pressure response to ramp exercise and exercise capacity in relation to age, gender, and mode of exercise in a healthy population. , 2013, Journal of cardiology.